Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-09

Clinical Trial Update: Effect of Rifaximine on Sleep Disorders in Patients Suffering From Hepatic Encephalopathy [NA]

View source ↗

Summary

Clinical trial updating the effects of rifaximin on sleep disorders in patients with hepatic encephalopathy; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rifaximin (rifaximin)

Snippet

Sponsor: Centre Hospitalier Universitaire Saint Pierre | Conditions: Hepatic Encephalopathy | NA | Status: COMPLETED | Results posted: 2019-04-09